<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05616351</url>
  </required_header>
  <id_info>
    <org_study_id>2022-01512; mu22Mueller2</org_study_id>
    <nct_id>NCT05616351</nct_id>
  </id_info>
  <brief_title>Antibiotic Therapy in Infections of the Diabetic Foot Syndrome</brief_title>
  <acronym>DFO</acronym>
  <official_title>Antibiotische Therapie In Infektionen Des Diabetischen Fusssyndroms</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Basel, Switzerland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This retrospective study examines the surgical and antibiotic treatment of diabetic foot&#xD;
      syndrome infections treated at the University Hospital Basel since 2019.&#xD;
&#xD;
      It analyses the implementation of the hospital in-house guidelines published in 2019 with&#xD;
      regard to antibiotic therapy in diabetic foot infections, taking into account clinical,&#xD;
      microbiological and histopathological criteria. The defined endpoints are (i) fully compliant&#xD;
      with internal policies, (ii) partially compliant with internal policies, and (iii) not&#xD;
      compliant with internal policies. The recording of these proportions is descriptive.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This retrospective study examines the surgical and antibiotic treatment of diabetic foot&#xD;
      syndrome infections treated at the University Hospital Basel since 2019. (In 2019 the&#xD;
      departments of infectiology and orthopedics at the University Hospital Basel published&#xD;
      recommendations with regard to the duration of antibiotic therapy in infections of the&#xD;
      diabetic foot syndrome. This depends on whether a surgical intervention was performed and&#xD;
      takes into account both the microbiological and the histopathological samples). Data that are&#xD;
      routinely collected in everyday clinical practice and stored in the hospitals' medical&#xD;
      records will be evaluated. The aim of this research project is to check the implementation of&#xD;
      these recommendations.&#xD;
&#xD;
      Inadequate use of antibiotics should thus be recognized. The study has the aspect of quality&#xD;
      control.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 12, 2022</start_date>
  <completion_date type="Anticipated">October 2023</completion_date>
  <primary_completion_date type="Anticipated">October 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Compliance with the hospital in-house guidelines for diabetic foot infections with regard to antibiotic treatment</measure>
    <time_frame>one time assessment at baseline</time_frame>
    <description>Implementation of the guidelines published in 2019 with regard to antibiotic therapy in diabetic foot infections, taking into account clinical, microbiological and histopathological criteria. The defined endpoints are (i) fully compliant with internal policies, (ii) partially compliant with internal policies, and (iii) not compliant with internal policies.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of antibiotic therapy (days)</measure>
    <time_frame>one time assessment at baseline</time_frame>
    <description>Duration of antibiotic therapy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relapse of diabetic foot infections (number)</measure>
    <time_frame>one time assessment at baseline</time_frame>
    <description>Relapse of diabetic foot infections (number)</description>
  </secondary_outcome>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Diabetic Foot Infection</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Data collection in patients with diabetic foot syndrome and infections in the area of the foot</intervention_name>
    <description>Data collection: on (surgical and antibiotic) treatment and implementation of the recommendations published 2019 with regard to the duration of antibiotic therapy.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The data in this retrospective study derive from everyday clinical work, collected between&#xD;
        January 1st, 2019 and December 31st, 2021 at the Department of Infectiology and Department&#xD;
        of Orthopaedics and Traumatology at the University Hospital Basel.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  soft tissue infection or bone infection (incl. osteomyelitis) in diabetic foot&#xD;
             syndrome&#xD;
&#xD;
          -  inpatient stay at the University Hospital Basel between January 1st, 2019 and December&#xD;
             31st, 2021&#xD;
&#xD;
          -  surgical intervention (amputation and/or debridement)&#xD;
&#xD;
          -  signed general consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  datasets without a diagnosis of the diabetic foot&#xD;
&#xD;
          -  no surgical intervention performed (amputation and/or debridement)&#xD;
&#xD;
          -  surgical interventions performed by disciplines other than orthopaedics/traumatology&#xD;
             (e.g. vascular surgery)&#xD;
&#xD;
          -  infections in osteosynthesis material (implant or fracture-associated infections)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andreas Marc Müller, Prof. Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Orthopaedics and Traumatology, University Hospital Basel</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Andreas Marc Müller, Prof. Dr. med.</last_name>
    <phone>+41 61 315 27 41</phone>
    <email>A.Mueller@usb.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Noémie Reinert, Dr. med.</last_name>
    <phone>+41 61 328 78 25</phone>
    <email>noemie.reinert@usb.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital Basel, Orthopedics and Traumatology</name>
      <address>
        <city>Basel</city>
        <zip>4031</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Noémie Reinert, Dr. med.</last_name>
      <phone>+41 61 328 78 25</phone>
      <email>noemie.reinert@usb.ch</email>
    </contact>
    <contact_backup>
      <last_name>Ilona Ahlborn</last_name>
      <email>ilona.ahlborn@usb.ch</email>
    </contact_backup>
    <investigator>
      <last_name>Noémie Reinert, Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>November 2022</verification_date>
  <study_first_submitted>November 7, 2022</study_first_submitted>
  <study_first_submitted_qc>November 7, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 15, 2022</study_first_posted>
  <last_update_submitted>November 7, 2022</last_update_submitted>
  <last_update_submitted_qc>November 7, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">November 15, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>diabetic foot syndrome</keyword>
  <keyword>antibiotic therapy</keyword>
  <keyword>soft tissue infection</keyword>
  <keyword>osteomyelitis</keyword>
  <keyword>bone infection</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Diabetic Foot</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

